OpenAI最新发声！距离超级智能“可能不到十年”

Core Insights - OpenAI has completed a capital restructuring, establishing a structure where a non-profit organization holds its for-profit business [2][6] - The restructuring aims to enhance OpenAI's operational efficiency and align its goals with long-term AI research objectives [4][6] Group 1: AI Research Goals - OpenAI has set a timeline for its internal research objectives, aiming to achieve a fully autonomous AI researcher by March 2028 [4] - The next immediate goal is to develop an AI research intern by September 2026, which is expected to significantly enhance the quality of models and accelerate researchers' work [4] - OpenAI believes that the development of superintelligent systems could occur within the next ten years, driven by advancements in deep learning [4] Group 2: Infrastructure Investments - OpenAI has disclosed its infrastructure investment, amounting to approximately $1.4 trillion, with a total commitment exceeding 30 gigawatts (GW) for infrastructure development [4] - A long-term goal includes establishing a factory capable of generating 1 GW of computing power weekly, with plans to reduce the cost per GW to around $20 billion over a five-year lifecycle [4] Group 3: Future Model Developments - OpenAI anticipates rapid advancements in its next-generation models within the coming months, although specific details about GPT-6 have not been disclosed [5] - The company aims to update its models more frequently to reflect ongoing developments and improvements in AI capabilities [5] Group 4: Organizational Structure and Financials - Following the restructuring, the non-profit organization is now called OpenAI Foundation, which holds approximately $130 billion in equity of its for-profit arm [6] - The for-profit entity is now designated as OpenAI Group PBC, a public benefit corporation, with Microsoft valuing its investment in OpenAI Group PBC at approximately $135 billion, representing a 27% stake [6] - OpenAI Foundation's first major commitment is a $25 billion investment in AI-assisted disease treatment research [6]